Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials
Top Cited Papers
- 1 April 2012
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 379 (9826), 1591-1601
- https://doi.org/10.1016/s0140-6736(12)60209-8
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trialsThe Lancet, 2012
- Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trialsThe Lancet, 2010
- Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trialsThe Lancet, 2010
- Aspirin Use and Survival After Diagnosis of Colorectal CancerJAMA, 2009
- Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statementThe Lancet Oncology, 2009
- Aspirin, salicylates, and cancerThe Lancet, 2009
- Low-dose aspirin and breast cancer risk: results by tumour characteristics from a randomised trialBritish Journal of Cancer, 2008
- Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studiesThe Lancet, 2007
- Long-term Use of Aspirin and Nonsteroidal Anti-inflammatory Drugs and Risk of Colorectal CancerJAMA, 2005
- ANTI-METASTATIC EFFECT OF ASPIRINThe Lancet, 1972